The interdisciplinary approach to investigate bona fide agent(s) in flavonoids or alkaloids in treating HCC
Source abstract
Abstract
Currently, the treatment of hepatocellular carcinoma (HCC) is yet to be determined, alternatively, flavonoids or alkaloids from nature have been considered as significant mediators against HCC. In the scenario, we pioneered the most significant agent(s) in either flavonoid(s) or alkaloid(s) against HCC with cheminformatics, bioinformatics, computer screening tools and quantum chemistry concept. In prospect, the intent was to provide the theoretical scaffold in the myriad natural organic molecules. The cheminformatics (natural product activity & species source database (NPASS), SwissADME, PubChem, Similarity Ensemble Approach (SEA) and SwissTargetPrediction (STP)), bioinformatics (DisGeNET, OMIM and STRING) were employed to underpin promising therapeutic components. The protein-protein interaction (PPI) network to identify the relationships between each target and a bubble chart to elucidate key signalling pathway(s) was constructed via STRING database. Ultimately, computer screening tools (PyMOL and AutoDockTools 1.5.6) and quantum chemistry (GaussView 6 and Gaussian) concept were adopted to decrypt the key molecule(s), target(s) and key mechanism(s). The most significant target was AKT1 in PPI network, AKT1 - isorhamnetin, MCL1 - ochrindole D and PIM1 - heyneanine hydroxyindolenine were the most stable conformers to antagonize JAK-STAT signalling pathway. This study provides scientific manifestation to facilitate the clinical test despite the enormous complexity of herbal medicine, and the devised platform for further clarifying the bioactive(s) and mechanism(s) against HCC.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Computational Drug Discovery Methods · Drug-Induced Hepatotoxicity and Protection · Cytokine Signaling Pathways and Interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Medicine, Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, South Korea
Funding
Ministry of Education, Science and Technology · Korea Institute for Advancement of Technology · Ministry of Trade, Industry and Energy · Hallym University Research Fund · the Basic Science Research Program through the National Research Foundation of Korea · Bio Industrial Technology Development Program
References (33)
Show source-provided references
1. 10.3390/molecules2522524310.3390/molecules25225243 ↗
2. 10.1007/978-3-030-58675-1_94-110.1007/978-3-030-58675-1_94-1 ↗
3. 10.3389/fphar.2022.108530910.3389/fphar.2022.1085309 ↗
4. 10.3350/cmh.2019.0049n10.3350/cmh.2019.0049n ↗
5. 10.3350/cmh.2023.011410.3350/cmh.2023.0114 ↗
6. 10.1016/S2225-4110(16)30051-710.1016/S2225-4110(16)30051-7 ↗
7. 10.1021/jacsau.2c0041510.1021/jacsau.2c00415 ↗
8. 10.1186/s12958-019-0546-z10.1186/s12958-019-0546-z ↗
9. Adole VA. Computational chemistry approach for the investigation of structural, electronic, chemical and quantum chemical facets of twelve Biginelli adducts. J Appl Organomet Chem. 2021;1(1):29–40.
10. 10.1007/s12263-014-0400-z10.1007/s12263-014-0400-z ↗
11. 10.3390/cells906145110.3390/cells9061451 ↗
12. 10.3390/ijms2204179410.3390/ijms22041794 ↗
13. 10.1016/j.compbiomed.2024.10826010.1016/j.compbiomed.2024.108260 ↗
14. 10.1179/isr.1995.20.2.13510.1179/isr.1995.20.2.135 ↗
15. 10.1155/2023/308142210.1155/2023/3081422 ↗
16. 10.1001/jama.2020.116610.1001/jama.2020.1166 ↗
17. 10.1016/j.joi.2021.10121610.1016/j.joi.2021.101216 ↗
18. 10.1038/nrd152310.1038/nrd1523 ↗
19. 10.1007/978-981-16-4345-3_710.1007/978-981-16-4345-3_7 ↗
20. 10.1016/j.proeng.2012.06.15610.1016/j.proeng.2012.06.156 ↗
21. 10.1021/acsomega.2c0761910.1021/acsomega.2c07619 ↗
22. Li J, Liu G, Zhen Z, et al. Molecular docking for ligand–receptor binding process based on heterogeneous computing. Sci Prog. 2022;2022(4):1–13.
23. 10.1016/j.apjtb.2016.12.01910.1016/j.apjtb.2016.12.019 ↗
24. 10.3390/molecules2604110910.3390/molecules26041109 ↗
25. 10.1016/j.drudis.2021.12.01710.1016/j.drudis.2021.12.017 ↗
26. 10.2217/hep-2020-000110.2217/hep-2020-0001 ↗
27. 10.1007/s10238-023-01047-810.1007/s10238-023-01047-8 ↗
28. 10.1016/j.ejmech.2020.11207610.1016/j.ejmech.2020.112076 ↗
29. 10.1186/1471-2407-6-23210.1186/1471-2407-6-232 ↗
30. 10.1002/path.549210.1002/path.5492 ↗
31. 10.1007/s12032-023-02050-510.1007/s12032-023-02050-5 ↗
32. 10.1016/j.fitote.2023.10543010.1016/j.fitote.2023.105430 ↗
33. Wang X, Liao X, Yu T, et al. Analysis of clinical significance and prospective molecular mechanism of main elements of the JAK/STAT pathway in hepatocellular carcinoma. Int J Oncol. 2019;55(4):805–822.